Global Low Dead Volume Syringe Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030

Global Low Dead Volume Syringe Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030

A low dead volume syringe or low dead space syringe is a type of syringe with a design that seeks to limit dead space that exists between the syringe hub and needle. Syringe dead space is the volume of residual fluid that remains within the syringe after the plunger is fully depressed during medication injection. The difference between a high dead space or a standard syringe and a low dead space syringe is determined by the amount of fluid that remains within the needle and syringe itself. When a patient injects his or her prescribed medications multiple times per week, the amount of waste can add up significantly. More medication can be lost when a new needle is attached for injection purposes. The low dead volume syringe has various colors, syringe volumes, needle gauge sizes, and needle length sizes, which could be applied in different clinic-use scenarios. Meanwhile, the device is sterilized with ethylene oxide and without any pyrogen. Therefore, this is a single-use device that should be immediately discarded after use.

Market Overview:

The latest research study on the global Low Dead Volume Syringe market finds that the global Low Dead Volume Syringe market reached a value of USD 313.64 million in 2023. It’s expected that the market will achieve USD 190.32 million by 2029, exhibiting a CAGR of -7.99% during the forecast period.

Low dead volume syringe industry chain is a general term for various related industries involved in upstream, midstream and downstream of low dead volume syringe. The upstream of low dead volume syringes mainly includes raw materials (Polypropylene, Epoxy Resin, Isoprene rubber, etc.) and outsourced accessories required for the production of low dead volume syringes. The midstream producers of low dead volume syringes are mainly responsible for the manufacture and sale of different types of low dead volume syringes.

Efficiency and high return on investment bring bright prospects

Efficiency and high return on investment is an important factor in running a healthcare enterprise, particularly if it is in the public sector where healthcare relies on the extent of the investment. This factor plays a great part in why the use of low dead space (LDS) syringes is so popular amongst healthcare providers in the rollout of the COVID-19 Vaccine, particularly the Pfizer Inc. Vaccine. The low dead space syringe in the long run results in very high return on investment, and overall huge cost savings. This means that governments can effectively provide more vaccines at the same cost. A simple innovation here will ensure that 20% more people will have access to a vaccine for no extra cost to government, resulting in an enhanced economic recovery rate from such a spend.

Low dead volume syringe market demand is unstable

Low dead space syringes are niche products and have traditionally been minimal market demand based on healthcare provider needs. Various intravenous drugs can be administered using LDS syringes. In ophthalmology, intravitreal drugs can also be injected using LDS syringes. Along with other vaccines, LDS syringes have also been used for COVID-19 vaccination during this pandemic. Within the syringe field, LDS syringe accounts for a small proportion, the market size is greatly affected by downstream demand, and the production of major manufacturers is determined by market demand. The fluctuation of market demand has a direct impact on the size of enterprises.

Region Overview:

In 2022, the share of the Low Dead Volume Syringe market in North America stood at 40.58%.

Company Overview:

Retractable Technologies, Inc.
Through innovation, education, and the development of safe and reliable money-saving medical devices, Retractable Technologies, Inc. strives to be a catalyst in reducing the worldwide spread of infectious disease.

B. Braun Medical Inc

B. Braun Medical, Inc. manufactures medical products. The Company offers admixture, dialysis, infusion therapy, duplex and premixed drugs, infusion pump systems, needle-free systems, and pain management products.

Retractable Technologies, Inc. is one of the major players operating in the Low Dead Volume Syringe market, holding a share of 18.04% in 2023.

Segmentation Overview:

By type, Detachable Needle Design segment accounted for the largest share of market in 2022.

Application Overview:

By application, the Public Sector segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Low Dead Volume Syringe market covered in Chapter 3:

Vernacare
Retractable Technologies, Inc.
B. Braun Medical Inc.
Rockmed Group
Sol-Millennium Medical Group
BD
Jiangsu Eyoung Medical Devices Co.,Ltd
Cardinal Health, Inc.
Poonglim Pharmatech Inc.
UltiMed, Inc.
MHC Medical Products, LLC
Nipro Corporation
MYCO Medical Supplies, Inc.
Arkray USA Inc.

In Chapter 4 and Chapter 14.2, on the basis of types, the Low Dead Volume Syringe market from 2019 to 2030 is primarily split into:

Fixed Needle Design
Detachable Needle Design

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Low Dead Volume Syringe market from 2019 to 2030 covers:

Public Sector
Private Sector

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2019-2030) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)